Our Mission: Real-Time Cancer Risk Insight

It’s not about age, but about stage.

At miRoncol, we believe that prevention begins with awareness — not just of family history or genetic predisposition, but of what’s happening inside the body right now. Our mission is to make real-time cancer risk assessment a standard part of preventive care, empowering individuals and healthcare providers with meaningful molecular insight.

Why We Exist

Cancer touches 1 in 3 people in their lifetime, yet more than 4 in 5 cancers are missed by current screening programs.
Screening is essential, but it is limited to certain cancers, age groups, and eligibility criteria.
We exist to close this gap by providing real-time molecular information that complements physician-led diagnostics and existing programs.

What We Do

miRoncol delivers the Real-time Multi-Cancer Early Risk Assessment a blood-based test that:

Detects microRNA biomarkers, sensitive signals of early cellular change
Uses AI-enhanced recognition trained from studies using human data involving 11,000+ samples
Covers more than a dozen common solid tumours
Provides specificity above 99% with high sensitivity for many cancers

Explore the Science Behind the Test

How We Do It

Prevention-first mindset: empowering individuals before symptoms appear
Collaboration with healthcare providers: results are designed to be interpreted with physicians
Ethical communication: ensuring results are shared responsibly, without overpromising
Scientific transparency: peer-reviewed publications, validated performance, and based on Nobel-recognized science

Our Vision

We envision a future where:

Real-time molecular testing is as routine as annual checkup
Prevention and early detection is prioritized alongside treatment
Millions of lives are saved through earlier awareness and follow-up

Next Step

Join us in shaping a prevention-forward future, where meaningful insight leads to more informed choices and healthier lives.

Meet Our Team Explore Our Scientific Advisory Board